Stéphanie Foulon

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

Karim Fizazi, Stéphanie Foulon, Joan Carles et al. · The Lancet · 2022 · 716 citations · Full text

Factorial Design, Urology, × 2 +9

Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial

David Malka, Pascale Cervera, Stéphanie Foulon et al. · The Lancet Oncology · 2014 · 409 citations · Full text

Advanced Biliary-tract Cancer, Gastrointestinal Oncology, Medicine +7

Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort

Laurence Albigès, Stéphanie Foulon, Arnaud Bayle et al. · Nature Cancer · 2020 · 117 citations · Full text

Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group

Stéphanie Foulon, Bernadette Brennan, Nathalie Gaspar et al. · European Journal of Cancer · 2016 · 89 citations

Euro-e.w.i.n.g Group, Surgical Oncology, Radiation Therapy +7

Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data

Stéphanie Foulon, Géric Maura, Marie Dalichampt et al. · Journal of Neurology · 2017 · 66 citations · Full text

Epidemiological Trend, Health Policy, Disease Progression +15